Report overview
The global Targeting p53 Cancer Therapies market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Small Molecule Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Targeting p53 Cancer Therapies include Sibiono GeneTech, Kartos Therapeutics, SynerGene Therapeutics, MultiVir, Rain Oncology, Alieron Therapeutics, Aprea Therapeutics, Ascentage Pharma and Jc (Wuxi) Company, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The essence of p53-targeted therapy is to regain the "tumor suppressor function" of the mutated p53 protein, or indirectly protect the "tumor suppressor function" of p53 by inhibiting other targets that can inhibit the wild-type p53 protein.
This report aims to provide a comprehensive presentation of the global market for Targeting p53 Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeting p53 Cancer Therapies. This report contains market size and forecasts of Targeting p53 Cancer Therapies in global, including the following market information:
Global Targeting p53 Cancer Therapies Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Targeting p53 Cancer Therapies Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Targeting p53 Cancer Therapies companies in 2023 (%)
We surveyed the Targeting p53 Cancer Therapies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeting p53 Cancer Therapies Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeting p53 Cancer Therapies Market Segment Percentages, by Type, 2023 (%)
Small Molecule Drugs
Immunotherapy
Gene Therapy
Others
Global Targeting p53 Cancer Therapies Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeting p53 Cancer Therapies Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Targeting p53 Cancer Therapies Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeting p53 Cancer Therapies Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeting p53 Cancer Therapies revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Targeting p53 Cancer Therapies revenues share in global market, 2023 (%)
Key companies Targeting p53 Cancer Therapies sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Targeting p53 Cancer Therapies sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sibiono GeneTech
Kartos Therapeutics
SynerGene Therapeutics
MultiVir
Rain Oncology
Alieron Therapeutics
Aprea Therapeutics
Ascentage Pharma
Jc (Wuxi) Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeting p53 Cancer Therapies, market overview.
Chapter 2: Global Targeting p53 Cancer Therapies market size in revenue and volume.
Chapter 3: Detailed analysis of Targeting p53 Cancer Therapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeting p53 Cancer Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Targeting p53 Cancer Therapies capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
